Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 49315-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 49315-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg/10ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 01)

20 mg/10ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 01)
This is a label for a medication called DOXOrubicin Hydrochloride liposome injection. It is a sterile solution that should be refrigerated and should not be frozen. It is a cytotoxic agent that must be diluted before intravenous administration. The label provides some dosage information, and notes that any unused solution should be discarded.*
FDA Label Image

20 mg/10 mL Carton Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 02)

20 mg/10 mL Carton Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 02)
This appears to be a label for a medication called DOXOrubicin Hydrochioride Liposome Injection. It is likely used for medical purposes, but further information is not available.*
FDA Label Image

50 mg/25ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 03)

50 mg/25ml Vial Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 03)
This is a description of the pharmaceutical product "DOXOrubicin Hydrochloride", which is a liposome injection used as a cytotoxic agent in cancer treatment. The product is manufactured by Cadila Healthcare Limited and is stored at 2° to 8°C (36° to 46°F) without freezing. The usual dosage is indicated in the package insert. The product is not to be substituted for DOXORUBICIN HCL and is for intravenous infusion only. The vial should be retained in the carton until the time of use.*
FDA Label Image

50 mg/25 mL Carton Label (Ad13df03 7d20 4ea9 Aaf2 0358a5e0ced3 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.